Skip to main content
Premium Trial:

Request an Annual Quote

Genomatix Licenses Software to NCI

NEW YORK, Sept. 20 (GenomeWeb News) - Genomatix Software said today that it has licensed its Genomatix Suite to the National Cancer Institute, allowing for 100 intramural researchers at all of the 21 NIH institutes to have full access to the software analysis tools and database.

 

The tools in GenomatixSuite are designed for analysis of gene regulatory networks and pathways, and also include a database of mammalian promoter DNA sequences, according to Genomatix.

 

Specific terms of the NCI deal were not disclosed.

 

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.